Table 5 Prevalence of CVD risk enhancing factors not included in risk scores in WHO/ISH charts by risk category
Cambodia (N = 3090) | Malaysia (N = 1618) | Mongolia (N = 764) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low (n = 3003) | Mod (n = 48) | High (n = 38) | Total | Low (n = 1484) | Mod (n = 60) | High (n = 60) | Total | Low (n = 674) | Mod (n = 36) | High (n = 54) | Total | |
Obesity | 2.3 (1.8-3.0) | 11.8 (4.7-26.2) | 0.9 (0.1-6.8) | 2.4 (1.9-3.1) | 15.3 (12.3-8.8) | 18.9 (14.6-4.2) | 34.0 (28.2-0.4) | 15.8 (13.0-9.1) | 23.9 (19.7-8.7) | 37.1 (21.8-55.3) | 42.0 (27.3-58.3) | 25.7 (21.6-30.3) |
Low physical activity | 9.7 (8.4-11.2) | 12.6 (5.5-26.3) | 6.1 (1.5-21.3) | 9.7 (8.4-11.2) | 27.4 (23.9-1.2) | 28.3 (18.3-1.2) | 14.3 (5.1-34.0) | 27.2 (23.7-1.0) | 8.3 (5.4-12.7) | 9.9 (2.5-32.2) | 16.3 (6.4-35.8) | 8.9 (5.8-13.5) |
High pulse rate | 15.3 (13.9-16.9) | 16.6 (8.4-30.0) | 30.1 (16.0-49.2) | 15.5 (14.1-17.1) | 6.6 (4.9-8.7) | 12.7 (7.9-19.7) | 18.5 (10.0-31.6) | 7.1 (5.4-9.1) | 14.1 (11.0-7.8) | 6.0 (1.4-21.9) | 20.4 (11.2-34.2) | 14.1 (11.3-17.5) |
Currently on HT medication | 6.2 (5.2-7.5) | 15.3 (7.5-28.7) | 43.7 (28.3-60.4) | 6.9 (5.8-8.2) | 12.3 (3.6-34.8) | 37.7 (20.8-58.3) | 31.9 (19.8-47.0) | 13.6 (4.3-35.4) | 18.8 (14.6-3.8) | 52.1 (33.2-70.5) | 68.7 (50.3-82.6) | 23.6 (18.9-29.1) |
High triglycerides | na | na | na | na | 27.5 (22.0-33.4) | 52.0 (45.3-58.5) | 40.9 (34.0-48.3) | 28.5 (23.5-34.1) | 18.8 (13.3-5.9) | 23.1 (10.6-43.1) | 7.0 (2.7-17.2) | 18.2 (13.2-24.6) |
Low HDL | na | na | na | na | 27.3 (24.0-30.9) | 25.8 (14.1-42.3) | 36.2 (29.0-44.1) | 27.4 (24.1-31.1) | 20.7 (14.9-7.9) | 38.0 (21.0-58.6) | 32.1 (19.1-48.4) | 22.2 (16.2-29.8) |